Matches in SemOpenAlex for { <https://semopenalex.org/work/W2389210069> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2389210069 abstract "Objective:To investigate the clinical efficacy of the combination of entecavir and interventional therapy in treatment of hepatitis B virus(HBV)-related hepatocellular carcinoma(HBVR-HCC).Methods:From February 2007 to February 2011,85 patients definitely diagnosed as HBVR-HCC and without indication for surgery were selected.Of the patients,44 cases underwent entecavir plus transarterial chemoembolization(TACE) treatment(observational group),and 41 cases received TACE alone(control group).The HBV DNA level,liver function,AFP level,and Child-Pugh score of the two groups before treatment and at 4,12,24,and 48 weeks after treatment were analyzed,and the clinical efficacy,incidence of adverse effects,and survival status between the two groups were compared.Results:With prolongation of treatment time,the HBV-DNA level in observational group was gradually decreased,while in control group it was gradually increased,and the differences at each time point after treatment between the two groups had statistical significance(P0.05);the alanine transaminase(ALT) and AFP levels were gradually decreased,but their decreasing degrees were greater than those in control group after 24-week treatment(all P0.05);the Child-Pugh scores in both groups were gradually increased but the increasing degree in observational group was significantly lower than that in control group after 24-week treatment(P0.05).The effective rate of treatment in observational group was significantly higher,while the incidence of complications and adverse reactions in observational group was significantly lower than those in control group(all P0.05).No statistical difference was noted in 1-year survival rate between the two groups(P0.05),but the 2-year survival rate and median survival time in observational group were better than those in control group(both P0.05).Conclusion:TACE may motivate the activity of HBV replication,and the combination of antiviral and TACE treatment for HBVR-HCC can effectively control HBV replication,and improve liver function without increase of side effects." @default.
- W2389210069 created "2016-06-24" @default.
- W2389210069 creator A5031521082 @default.
- W2389210069 date "2014-01-01" @default.
- W2389210069 modified "2023-09-23" @default.
- W2389210069 title "Clinical efficacy of combined entecavir and interventional therapy in treatment of hepatitis B virus-related hepatocellular carcinoma" @default.
- W2389210069 hasPublicationYear "2014" @default.
- W2389210069 type Work @default.
- W2389210069 sameAs 2389210069 @default.
- W2389210069 citedByCount "0" @default.
- W2389210069 crossrefType "journal-article" @default.
- W2389210069 hasAuthorship W2389210069A5031521082 @default.
- W2389210069 hasConcept C120665830 @default.
- W2389210069 hasConcept C121332964 @default.
- W2389210069 hasConcept C126322002 @default.
- W2389210069 hasConcept C197934379 @default.
- W2389210069 hasConcept C203014093 @default.
- W2389210069 hasConcept C23131810 @default.
- W2389210069 hasConcept C2522874641 @default.
- W2389210069 hasConcept C2776175608 @default.
- W2389210069 hasConcept C2777382497 @default.
- W2389210069 hasConcept C2777869810 @default.
- W2389210069 hasConcept C2778019345 @default.
- W2389210069 hasConcept C2780593183 @default.
- W2389210069 hasConcept C2992208098 @default.
- W2389210069 hasConcept C61511704 @default.
- W2389210069 hasConcept C65409693 @default.
- W2389210069 hasConcept C71924100 @default.
- W2389210069 hasConcept C90924648 @default.
- W2389210069 hasConceptScore W2389210069C120665830 @default.
- W2389210069 hasConceptScore W2389210069C121332964 @default.
- W2389210069 hasConceptScore W2389210069C126322002 @default.
- W2389210069 hasConceptScore W2389210069C197934379 @default.
- W2389210069 hasConceptScore W2389210069C203014093 @default.
- W2389210069 hasConceptScore W2389210069C23131810 @default.
- W2389210069 hasConceptScore W2389210069C2522874641 @default.
- W2389210069 hasConceptScore W2389210069C2776175608 @default.
- W2389210069 hasConceptScore W2389210069C2777382497 @default.
- W2389210069 hasConceptScore W2389210069C2777869810 @default.
- W2389210069 hasConceptScore W2389210069C2778019345 @default.
- W2389210069 hasConceptScore W2389210069C2780593183 @default.
- W2389210069 hasConceptScore W2389210069C2992208098 @default.
- W2389210069 hasConceptScore W2389210069C61511704 @default.
- W2389210069 hasConceptScore W2389210069C65409693 @default.
- W2389210069 hasConceptScore W2389210069C71924100 @default.
- W2389210069 hasConceptScore W2389210069C90924648 @default.
- W2389210069 hasLocation W23892100691 @default.
- W2389210069 hasOpenAccess W2389210069 @default.
- W2389210069 hasPrimaryLocation W23892100691 @default.
- W2389210069 hasRelatedWork W1737609216 @default.
- W2389210069 hasRelatedWork W1985624846 @default.
- W2389210069 hasRelatedWork W2041137562 @default.
- W2389210069 hasRelatedWork W2366526583 @default.
- W2389210069 hasRelatedWork W2373659806 @default.
- W2389210069 hasRelatedWork W2374431816 @default.
- W2389210069 hasRelatedWork W2374447323 @default.
- W2389210069 hasRelatedWork W2375255062 @default.
- W2389210069 hasRelatedWork W2382968665 @default.
- W2389210069 hasRelatedWork W2383599129 @default.
- W2389210069 hasRelatedWork W2385469193 @default.
- W2389210069 hasRelatedWork W2385549144 @default.
- W2389210069 hasRelatedWork W2385977286 @default.
- W2389210069 hasRelatedWork W2394276610 @default.
- W2389210069 hasRelatedWork W2394466133 @default.
- W2389210069 hasRelatedWork W2554764838 @default.
- W2389210069 hasRelatedWork W2608559068 @default.
- W2389210069 hasRelatedWork W3032732545 @default.
- W2389210069 hasRelatedWork W3142400813 @default.
- W2389210069 hasRelatedWork W3180122705 @default.
- W2389210069 isParatext "false" @default.
- W2389210069 isRetracted "false" @default.
- W2389210069 magId "2389210069" @default.
- W2389210069 workType "article" @default.